Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKesson
Chinese Patent Office
Harvard Business School
Fish and Richardson
Johnson and Johnson
Argus Health
Citi
Express Scripts
Julphar

Generated: February 24, 2018

DrugPatentWatch Database Preview

LIDOCAINE HYDROCHLORIDE - Generic Drug Details

« Back to Dashboard

What are the generic sources for lidocaine hydrochloride and what is the scope of lidocaine hydrochloride patent protection?

Lidocaine hydrochloride
is the generic ingredient in thirty-five branded drugs marketed by Akorn, Carlisle, Abbott, Abraxis Pharm, Aurobindo Pharma Ltd, Bel Mar, Belmora Llc, Dell Labs, Elkins Sinn, Gd Searle Llc, Hospira, Intl Medication, Luitpold, Luitpold Pharms Inc, Lyphomed, Miles, Mylan Labs Ltd, Watson Labs, West-ward Pharms Int, Wyeth Ayerst, Baxter Hlthcare, B Braun, Fresenius Kabi Usa, Pharmaton, Meridian Medcl Techn, Astrazeneca, Dentsply Pharm, Bionpharma Inc, Sagent Pharms, G And W Labs Inc, Watson Labs Inc, Oak Pharms, Hi Tech Pharma, Wockhardt Bio Ag, Actavis Mid Atlantic, Vintage, Kendall Il, Paco, Teligent Pharma Inc, Powder Pharms, and Pfizer, and is included in ninety-nine NDAs. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Lidocaine hydrochloride has fifteen patent family members in ten countries.

There are twenty-nine drug master file entries for lidocaine hydrochloride. Forty-three suppliers are listed for this compound.
Summary for LIDOCAINE HYDROCHLORIDE

US Patents and Regulatory Information for LIDOCAINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Ayerst LIDOCAINE HYDROCHLORIDE lidocaine hydrochloride INJECTABLE;INJECTION 083083-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Akorn LIDOCAINE HYDROCHLORIDE lidocaine hydrochloride INJECTABLE;INJECTION 085037-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Astrazeneca XYLOCAINE lidocaine hydrochloride INJECTABLE;INJECTION 010418-009 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lyphomed LIDOCAINE HYDROCHLORIDE lidocaine hydrochloride INJECTABLE;INJECTION 080390-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
West-ward Pharms Int LIDOCAINE HYDROCHLORIDE lidocaine hydrochloride INJECTABLE;INJECTION 080407-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Meridian Medcl Techn LIDOPEN lidocaine hydrochloride INJECTABLE;INJECTION 017549-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Abraxis Pharm LIDOCAINE HYDROCHLORIDE lidocaine hydrochloride INJECTABLE;INJECTION 086761-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Astrazeneca XYLOCAINE 5% W/ GLUCOSE 7.5% lidocaine hydrochloride INJECTABLE;SPINAL 010496-002 Jul 7, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Abraxis Pharm LIDOCAINE HYDROCHLORIDE lidocaine hydrochloride INJECTABLE;INJECTION 086761-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Belmora Llc LIDOCAINE HYDROCHLORIDE lidocaine hydrochloride INJECTABLE;INJECTION 080504-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for LIDOCAINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Powder Pharms ZINGO lidocaine hydrochloride SYSTEM;INTRADERMAL 022114-001 Aug 16, 2007 ➤ Try a Free Trial ➤ Try a Free Trial
Powder Pharms ZINGO lidocaine hydrochloride SYSTEM;INTRADERMAL 022114-001 Aug 16, 2007 ➤ Try a Free Trial ➤ Try a Free Trial
Powder Pharms ZINGO lidocaine hydrochloride SYSTEM;INTRADERMAL 022114-001 Aug 16, 2007 ➤ Try a Free Trial ➤ Try a Free Trial
Powder Pharms ZINGO lidocaine hydrochloride SYSTEM;INTRADERMAL 022114-001 Aug 16, 2007 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for LIDOCAINE HYDROCHLORIDE

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,044,546 Particle cassettes and processes therefor ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for LIDOCAINE HYDROCHLORIDE

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Moodys
Chinese Patent Office
Harvard Business School
Mallinckrodt
Express Scripts
QuintilesIMS
Dow
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot